Skip to Content
Jump to the top of the page

The Eimen Kaminski Group

William Blair Private Wealth Management

The Eimen-Kaminski Team

About William Blair

William Blair is a premier global partnership with expertise in investment banking, investment management, and private wealth management. We provide advisory services, strategies, and solutions to meet our clients’ evolving needs. As an independent and employee-owned firm, together with our strategic partners, we operate in more than 30 offices worldwide.*

  • 1935

    Year William Blair was founded

  • 1,950+

    Employees worldwide

  • 145 billion+

    Client assets

  • 90+ Years

    Independent and employee-owned

  • 30+

    Offices worldwide*

  • 700+

    Companies under coverage

As of March 31, 2026
*Includes strategic partnerships with Allier Capital, BDA Partners, and Poalim Equity.

More about William Blair affiliated entities

Thought Leadership

  • Back of students' heads wearing caps and gowns

    College Was Awesome. Now What?

    College graduation marks the start of a career with new responsibilities and decisions. It can be an exciting time but filled with uncertainty.

    Read more
  • Asset Allocation: Your Biggest Investment Decision

    Building a portfolio involves countless decisions. But none is more important than how you allocate your wealth across asset classes. This white paper describes the process of developing a customized asset-allocation strategy, achieving meaningful diversification across and within asset classes, and monitoring allocations and reviewing portfolios.

    Read more
  • 2026 Wealth Planning and Philanthropy Strategies

    As we kick off 2026, now is the time to review your financial strategy and position yourself for success in the year ahead.

    Read more

Our Latest News

  • Thibaut Has Been Acquired by Quad-C

    William Blair acted as financial advisor to Thibaut, a portfolio company of Norwest Equity Partners, in connection with its sale to Quad-C Management.

    Read more
  • Kailera Therapeutics, Inc.: Initiation of Research Coverage

    William Blair initiated research coverage of Kailera Therapeutics, Inc. (KLRA $21.47). Kailera is advancing a portfolio of GLP-1-based obesity assets, including mono, dual, and triple agonists with both injectable and oral formats.

    Read more
  • AEVEX Corp.: Initiation of Research Coverage

    William Blair initiated research coverage of Aevex Corp. (AVEX $25.07), which designs, manufactures, and deploys mission-critical autonomous systems and ISR solutions for defense and national security operations.

    Read more

Ready to start a conversation? Contact us today.

This content is for informational and educational purposes only and not intended as investment advice or a recommendation to buy or sell any security. Investment advice and recommendations can be provided only after careful consideration of an investor's objectives, guidelines, and restrictions.

Copyright © 2025 William Blair & Company, L.L.C. | Privacy Terms

Are you sure you want to leave?

Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.

For disclosure information, please visit www.williamblair.com/disclosures